Market Research Logo

Infectious Diseases 2016-2020: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts for 100 Tests, Innovative Technologies, Instrumentation Review

Infectious Diseases 2016-2020: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts for 100 Tests, Innovative Technologies, Instrumentation Review

This comprehensive seven-country report contains 1,954 pages, 824 tables, and is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expand ing infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The report provides market segmentation analysis of over 100 diseases and viruses in seven countries; assessment of emerging technologies; review of current instrumentation; as well as strategic profiles of leading suppliers and recent market entrants with innovative technologies and products.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,Cand ida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Geographic Coverage

- France- Germany- Italy- Japan- Spain- UK- U

Market Segmentation Analysis

- Sales and market shares of major suppliers of infectious disease diagnostic products, by country and individual test. - Test and sales forecasts for over 90 infectious disease diagnostic assays by country, individual test and market segment:

- Hospitals - Blood Banks - Commercial/Private Laboratories - Physician Offices/Group Practices - Public Health Laboratories - Review of market dynamics, trends, structure, size, growth and major suppliers by country.

Current and Emerging Products

- In-depth examination of over 90 major diseases, including etiology, current diagnostic tests, vaccines, drugs and market needs. - Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody, immunoassay,and other technologies and their potential applications for infectious disease testing. - Extensive listings of companies developing or marketing infectious disease diagnostic products worldwide by individual test.

Competitive Assessments

- Detailed strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Worldwide Market Overview

- Estimated universe of laboratories performing infectious disease testing by country. - Test volume and sales projections for major infectious disease diagnostic assays by country.

Opportunities and Strategic Recommendations

- Emerging opportunities for new instrumentation, reagents, IT and other products with significant market appeal during the next five years. - Design criteria for decentralized testing products. - Alternative market penetration strategies. - Potential market entry barriers and risks.

Contains

1,954 pages and 824 tablesSummary

This comprehensive seven-country report contains 650 pages, 150 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global coagulation testing market during the next five years.

The report explores business and technological trends in the US, Europe (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years

Rationale

The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the global coagulation diagnostics practice during the next five years.

New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more stand ardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.

Coagulation Tests

Activated Clotting Time (ACT) (1), Activated Protein C Resistance,Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX,Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand 's Factor Fav/Ag, and others.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Sales and Market Share Analysis

- Sales and market shares of major instrument and reagent suppliers.

Competitive Assessments

- Extensive strategic profiles ofmajor suppliers and emerging market entrants

Market Segmentation Analysis

- Comprehensive marketsegmentation analysis, including:

- Hospitals - Commercial/Private Laboratories - Physician Offices - Ambulatory Care Centers - Test volume forecasts for over 40 major procedures,by country and market segment.

Current and Emerging Products

- Review of established and emerging procedures. - Comparison of automated and semi-automatedanalyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.

Technology Review

- Analysis of current and emerging technologies and their potential market applications. - Comprehensive lists of companies developingor marketing new technologies and products by test.

Worldwide Market Overview

- Estimates of facilities performing coagulation testsby country. - Test volume and sales projections by country.

Strategic Recommendations

- Product development and business expansion opportunities with significant market appeal. - “Ideal” product models with tentativeprices and operating characteristics. - Alternative market penetrationstrategies for instrument and reagent suppliers. - Potential market entry barriers and risks.

Contains

650 pages and 150 table's

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


TOC available on request

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report